The future of mental health is being transformed, moving beyond trial-and-error treatments to science-driven precision. Breakthroughs in neuroscience, AI, and precision medicine are mapping the brain’s unique biological signatures, creating pathways for personalized care. Alto Neuroscience is at the forefront, using brain biomarkers and AI to match patients with the right therapies—fast. Founded in 2019 by Dr. Amit Etkin, the company is rewriting the rules of mental health treatment. He goes Inside the ICE house to explain how Alto is turning guesswork into guided science and offering hope where it once felt out of reach.
Up Next in 2025 | Inside the ICE House
-
AI, Ambition, and Innovation with Hum...
Artificial intelligence is reshaping industries by unlocking insights hidden within massive amounts of unstructured data. With powerful tools like vector databases and enterprise platforms, AI is driving breakthroughs across healthcare, finance, and entertainment. Pinecone founder Edo Liberty and...
-
W&T Offshore CEO Tracy Krohn on Steer...
The offshore oil and gas industry fuels progress by unlocking hidden energy reserves deep beneath the ocean’s surface. With advanced technology, it thrives in some of the world’s harshest environments to power industries, transportation, and daily life. W&T Offshore has been a leader in this spac...
-
Houlihan Lokey CEO Scott Adelson on M...
The M&A landscape has rebounded in 2025, driven by stable interest rates, improved market conditions, and rising CEO confidence. Strategic buyers are fueling the surge, targeting deals that boost growth, expand capabilities, and enhance competitive positioning. Houlihan Lokey has emerged as the g...
